This paper is in the following e-collection/theme issue:

Chatbots and Conversational Agents (531) Consumer & Patient Education and Shared-Decision Making (679) mHealth for Screening (213) Breast Cancer (206) Cancer Self-Management (51) Innovations and Technology in Cancer Care (423) Innovations and Technology in Cancer Research (33) Mobile Apps for Cancer Care and Cancer Prevention and Screening (206)

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46571, first published .
Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study

Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study

Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study

Authors of this article:

Elen Siglen1, 2 Author Orcid Image ;   Hildegunn Høberg Vetti1, 2 Author Orcid Image ;   Mirjam Augestad2 Author Orcid Image ;   Vidar M Steen1, 3 Author Orcid Image ;   Åshild Lunde4 Author Orcid Image ;   Cathrine Bjorvatn1, 2 Author Orcid Image
Article Authors Cited by (7) Tweetations (3) Metrics

Journals

  1. Nääs C, von Salomé J, Rosén A. Patients’ perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. European Journal of Human Genetics 2024;32(4):448 View
  2. Laymouna M, Ma Y, Lessard D, Schuster T, Engler K, Lebouché B. Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review. Journal of Medical Internet Research 2024;26:e56930 View
  3. Ozcelik F, Dundar M, Yildirim A, Henehan G, Vicente O, Sánchez-Alcázar J, Gokce N, Yildirim D, Bingol N, Karanfilska D, Bertelli M, Pojskic L, Ercan M, Kellermayer M, Sahin I, Greiner-Tollersrud O, Tan B, Martin D, Marks R, Prakash S, Yakubi M, Beccari T, Lal R, Temel S, Fournier I, Ergoren M, Mechler A, Salzet M, Maffia M, Danalev D, Sun Q, Nei L, Matulis D, Tapaloaga D, Janecke A, Bown J, Cruz K, Radecka I, Ozturk C, Nalbantoglu O, Sag S, Ko K, Arngrimsson R, Belo I, Akalin H, Dundar M. The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution. Functional & Integrative Genomics 2024;24(4) View
  4. Kaphingst K, Kohlmann W, Lorenz Chambers R, Bather J, Goodman M, Bradshaw R, Chavez-Yenter D, Colonna S, Espinel W, Everett J, Flynn M, Gammon A, Harris A, Hess R, Kaiser-Jackson L, Lee S, Monahan R, Schiffman J, Volkmar M, Wetter D, Zhong L, Mann D, Ginsburg O, Sigireddi M, Kawamoto K, Del Fiol G, Buys S. Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models. JAMA Network Open 2024;7(9):e2432143 View
  5. Tagliaferri L, Fionda B, Casà C, Cornacchione P, Scalise S, Chiesa S, Marconi E, Dinapoli L, Di Capua B, Chieffo D, Marazzi F, Frascino V, Colloca G, Valentini V, Miccichè F, Gambacorta M. Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art. Strahlentherapie und Onkologie 2024 View
  6. Russell C, Daley A, Van Arnem D, Hila A, Johnson K, Davies J, Cytron H, Ready K, Armstrong C, Sylvester M, Caleshu C. Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing. Hereditary Cancer in Clinical Practice 2024;22(1) View

Books/Policy Documents

  1. Yuen J, De Guzman A, Courtney E, Ngeow J. International Encyclopedia of Public Health. View